Healthcare provider profile · identity verified

Pankaj Garg, M.D.

Internal Medicine · BROCKPORT, NY · NPI 1043269335

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	443	147
Levothyroxine Sodium	Levothyroxine Sodium	382	116
Atorvastatin Calcium	Atorvastatin Calcium	275	89
Losartan Potassium	Losartan Potassium	254	91
Amlodipine Besylate	Amlodipine Besylate	210	76
Torsemide	Torsemide	208	63
Metoprolol Succinate	Metoprolol Succinate	206	68
Pantoprazole Sodium	Pantoprazole Sodium	191	67
Lisinopril	Lisinopril	179	52
Pregabalin	Pregabalin	158	44
Ezetimibe	Ezetimibe	156	53
Famotidine	Famotidine	151	59
Metformin Hcl	Metformin Hcl	151	57
Celecoxib	Celecoxib	150	53
Omeprazole	Omeprazole	147	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	140	33
Alprazolam	Alprazolam	130	38
Bisoprolol Fumarate	Bisoprolol Fumarate	125	40
Prednisone	Prednisone	124	84
Pravastatin Sodium	Pravastatin Sodium	117	35
Tamsulosin Hcl	Tamsulosin Hcl	117	38
Cephalexin	Cephalexin	112	77
Spironolactone	Spironolactone	110	33
Metoprolol Tartrate	Metoprolol Tartrate	108	37
Baclofen	Baclofen	103	46
Hydralazine Hcl	Hydralazine Hcl	103	31
Ozempic	Semaglutide	101	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	98	22
Gabapentin	Gabapentin	96	31
Propranolol Hcl Er	Propranolol Hcl	93	30
Albuterol Sulfate Hfa	Albuterol Sulfate	92	43
Nateglinide	Nateglinide	91	30
Duloxetine Hcl	Duloxetine Hcl	88	29
Allopurinol	Allopurinol	84	30
Nebivolol Hcl	Nebivolol Hcl	83	22
Zolpidem Tartrate	Zolpidem Tartrate	82	22
Hydrochlorothiazide	Hydrochlorothiazide	81	32
Chlorthalidone	Chlorthalidone	78	30
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	78	21
Alendronate Sodium	Alendronate Sodium	77	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	74	23
Valsartan	Valsartan	73	20
Bumetanide	Bumetanide	72	22
Escitalopram Oxalate	Escitalopram Oxalate	72	24
Eliquis	Apixaban	71	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	68	52
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	67	23
Ciprofloxacin Hcl	Ciprofloxacin Hcl	66	50
Risedronate Sodium	Risedronate Sodium	66	23
Felodipine Er	Felodipine	65	22
Acetaminophen-Codeine	Acetaminophen With Codeine	59	37
Memantine Hcl	Memantine Hcl	59	19
Dexamethasone	Dexamethasone	58	47
Solifenacin Succinate	Solifenacin Succinate	56	18
Calcitriol	Calcitriol	54	29
Glimepiride	Glimepiride	54	21
Warfarin Sodium	Warfarin Sodium	53	15
Doxycycline Hyclate	Doxycycline Hyclate	52	42
Sertraline Hcl	Sertraline Hcl	51	14
Trazodone Hcl	Trazodone Hcl	48	13
Azithromycin	Azithromycin	46	32
Atenolol	Atenolol	45	15
Clopidogrel	Clopidogrel Bisulfate	44	14
Furosemide	Furosemide	42	16
Labetalol Hcl	Labetalol Hcl	41	14
Potassium Chloride	Potassium Chloride	41	14
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Carvedilol	Carvedilol	39	14
Januvia	Sitagliptin Phosphate	39	12
Nortriptyline Hcl	Nortriptyline Hcl	39	13
Myrbetriq	Mirabegron	37	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	14
Montelukast Sodium	Montelukast Sodium	36	14
Fluconazole	Fluconazole	35	18
Betamethasone Valerate	Betamethasone Valerate	33	31
Cilostazol	Cilostazol	33	11
Clonidine Hcl	Clonidine Hcl	33	12
Fluticasone Propionate	Fluticasone Propionate	32	18
Lovastatin	Lovastatin	31	suppressed
Amoxicillin	Amoxicillin	30	24
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	30	19
Enalapril Maleate	Enalapril Maleate	29	suppressed
Meloxicam	Meloxicam	29	12
Mirtazapine	Mirtazapine	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Simvastatin	Simvastatin	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	11
Irbesartan	Irbesartan	27	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	27	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	11
Verapamil Er	Verapamil Hcl	26	12
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	13
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	11
Lorazepam	Lorazepam	23	12
Levofloxacin	Levofloxacin	22	18
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	20
Topiramate	Topiramate	21	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Clindamycin Hcl	Clindamycin Hcl	20	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Finasteride	Finasteride	19	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	19	suppressed
Glipizide	Glipizide	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	17	suppressed
Humulin R	Insulin Regular, Human	17	suppressed
Megestrol Acetate	Megestrol Acetate	17	suppressed
Methimazole	Methimazole	17	suppressed
Primidone	Primidone	17	suppressed
Albuterol Sulfate	Albuterol Sulfate	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	14
Digoxin	Digoxin	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Verapamil Sr	Verapamil Hcl	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Mirabegron Er	Mirabegron	13	suppressed
Moxifloxacin Hcl	Moxifloxacin Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Chlordiazepoxide-Clidinium	Chlordiazepoxide/Clidinium Br	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Tramadol Hcl	Tramadol Hcl	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Diazepam	Diazepam	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error